Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 110

1.

Ethambutol-resistant Mycobacterium kansasii cervical lymphadenitis in an immunocompetent adult patient: A case report and literature review.

Asensi V, Palacios JJ, Rivas-Carmenado M, Suárez-Zarracina T, Garcia-Carus E, Fernández LM, Torres HE, Fierer J, Carton JA.

J Clin Tuberc Other Mycobact Dis. 2019 Dec 6;18:100137. doi: 10.1016/j.jctube.2019.100137. eCollection 2020 Feb.

2.

The N125S polymorphism in the cathepsin G gene (rs45567233) is associated with susceptibility to osteomyelitis in a Spanish population.

Pérez-Is L, Ocaña MG, Montes AH, Carton JA, Álvarez V, Meana Á, Fierer J, Valle-Garay E, Asensi V.

PLoS One. 2019 Oct 24;14(10):e0220022. doi: 10.1371/journal.pone.0220022. eCollection 2019.

3.

Observational Needs for Improving Ocean and Coupled Reanalysis, S2S Prediction, and Decadal Prediction.

Penny SG, Akella S, Balmaseda MA, Browne P, Carton JA, Chevallier M, Counillon F, Domingues C, Frolov S, Heimbach P, Hogan P, Hoteit I, Iovino D, Laloyaux P, Martin MJ, Masina S, Moore AM, de Rosnay P, Schepers D, Sloyan BM, Storto A, Subramanian A, Nam S, Vitart F, Yang C, Fujii Y, Zuo H, O'Kane T, Sandery P, Moore T, Chapman CC.

Front Mar Sci. 2019 Jul;6:391. doi: 10.3389/fmars.2019.00391.

PMID:
31534949
4.

Factors predictive of relapse in adult bacterial osteomyelitis of long bones.

Garcia Del Pozo E, Collazos J, Carton JA, Camporro D, Asensi V.

BMC Infect Dis. 2018 Dec 7;18(1):635. doi: 10.1186/s12879-018-3550-6.

5.

Bacterial osteomyelitis: microbiological, clinical, therapeutic, and evolutive characteristics of 344 episodes.

García Del Pozo E, Collazos J, Cartón JA, Camporro D, Asensi V.

Rev Esp Quimioter. 2018 Jun;31(3):217-225. Epub 2018 May 11.

6.

A fatal case of Babesia divergens infection in Northwestern Spain.

Asensi V, González LM, Fernández-Suárez J, Sevilla E, Navascués RÁ, Suárez ML, Lauret ME, Bernardo A, Carton JA, Montero E.

Ticks Tick Borne Dis. 2018 Mar;9(3):730-734. doi: 10.1016/j.ttbdis.2018.02.018. Epub 2018 Feb 21.

PMID:
29496491
7.

Matrix metalloproteases and their tissue inhibitors in non-alcoholic liver fibrosis of human immunodeficiency virus-infected patients.

Collazos J, Valle-Garay E, Suárez-Zarracina T, Montes AH, Cartón JA, Asensi V.

World J Virol. 2017 May 12;6(2):36-45. doi: 10.5501/wjv.v6.i2.36.

8.

Factors associated with long-term CD4 cell recovery in HIV-infected patients on successful antiretroviral therapy.

Collazos J, Valle-Garay E, Carton JA, Montes AH, Suarez-Zarracina T, De la Fuente B, Asensi V.

HIV Med. 2016 Aug;17(7):532-41. doi: 10.1111/hiv.12354. Epub 2016 Jan 11.

9.

CD4⁺CD28null T lymphocytes resemble CD8⁺CD28null T lymphocytes in their responses to IL-15 and IL-21 in HIV-infected patients.

Echeverría A, Moro-García MA, Asensi V, Cartón JA, López-Larrea C, Alonso-Arias R.

J Leukoc Biol. 2015 Sep;98(3):373-84. doi: 10.1189/jlb.1A0514-276RR. Epub 2015 Jun 1.

PMID:
26034206
10.

Differential body composition effects of protease inhibitors recommended for initial treatment of HIV infection: a randomized clinical trial.

Martinez E, Gonzalez-Cordon A, Ferrer E, Domingo P, Negredo E, Gutierrez F, Portilla J, Curran A, Podzamczer D, Ribera E, Murillas J, Bernardino JI, Santos I, Carton JA, Peraire J, Pich J, Deulofeu R, Perez I, Gatell JM; ATADAR Study Group.

Clin Infect Dis. 2015 Mar 1;60(5):811-20. doi: 10.1093/cid/ciu898. Epub 2014 Nov 10.

11.

Endothelial (NOS3 E298D) and inducible (NOS2 exon 22) nitric oxide synthase polymorphisms, as well as plasma NOx, influence sepsis development.

Martin G, Asensi V, Montes AH, Collazos J, Alvarez V, Pérez-Is L, Carton JA, Taboada F, Valle-Garay E.

Nitric Oxide. 2014 Nov 15;42:79-86. doi: 10.1016/j.niox.2014.09.004. Epub 2014 Sep 16.

PMID:
25239655
12.

Role of plasma matrix-metalloproteases (MMPs) and their polymorphisms (SNPs) in sepsis development and outcome in ICU patients.

Martin G, Asensi V, Montes AH, Collazos J, Alvarez V, Carton JA, Taboada F, Valle-Garay E.

Sci Rep. 2014 May 16;4:5002. doi: 10.1038/srep05002.

13.

Immune reconstitution inflammatory syndrome-Unmasking endophthalmic, lymphadenopathic, and neuromeningeal cryptococcosis in an HIV-infected patient starting highly active antiretroviral therapy.

Martinez-Zapico A, Asensi V, Fuentes N, Fonollá M, Rodriguez M, Cárcaba V, Carton JA.

AIDS Res Hum Retroviruses. 2014 May;30(5):434-5. doi: 10.1089/AID.2014.0039. No abstract available.

PMID:
24724818
14.

Early lipid changes with atazanavir/ritonavir or darunavir/ritonavir.

Martinez E, Gonzalez-Cordon A, Ferrer E, Domingo P, Negredo E, Gutierrez F, Portilla J, Curran A, Podzamczer D, Murillas J, Bernardino JI, Santos I, Carton JA, Peraire J, Pich J, Perez I, Gatell JM; ATADAR Study Group.

HIV Med. 2014 Jul;15(6):330-8. doi: 10.1111/hiv.12121. Epub 2014 Jan 12.

15.

The effect of unsuccessful treatment with peginterferon and ribavirin on the liver fibrosis course of HIV/HCV-coinfected patients.

Collazos J, Asensi V, de la Fuente B, Cartón JA.

Curr HIV Res. 2012 Dec;10(8):679-87.

PMID:
23061599
16.

Didanosine (ddI) associates with increased liver fibrosis in adult HIV-HCV coinfected patients.

Suárez-Zarracina T, Valle-Garay E, Collazos J, Montes AH, Cárcaba V, Carton JA, Asensi V.

J Viral Hepat. 2012 Oct;19(10):685-93. doi: 10.1111/j.1365-2893.2012.01596.x. Epub 2012 Mar 15.

PMID:
22967099
17.

Course of liver fibrosis in HIV-hepatitis C virus-coinfected patients depending on the response to hepatitis C therapy.

Cartón JA, Collazos J, de la Fuente B, Asensi V.

AIDS Res Hum Retroviruses. 2013 Feb;29(2):215-22. doi: 10.1089/AID.2012.0108. Epub 2012 Jul 31.

PMID:
22734850
18.

Liver toxicity of initial antiretroviral drug regimens including two nucleoside analogs plus one non-nucleoside analog or one ritonavir-boosted protease inhibitor in HIV/HCV-coinfected patients.

Macías J, Neukam K, Mallolas J, López-Cortés LF, Cartón JA, Domingo P, Moreno S, Iribarren JA, Clotet B, Crespo M, de Los Santos I, Ortega E, Knobel H, Jiménez-Expósito MJ, Pineda JA; COINS Study Team.

HIV Clin Trials. 2012 Mar-Apr;13(2):61-9. doi: 10.1310/hct1302-61.

PMID:
22510353
19.

Hepatic safety of efavirenz in HIV/hepatitis C virus-coinfected patients with advanced liver fibrosis.

Pineda JA, Neukam K, Mallolas J, López-Cortés LF, Cartón JA, Domingo P, Moreno S, Iribarren JA, Clotet B, Crespo M, de Los Santos I, Ortega E, Knobel H, Jiménez-Expósito MJ, Macías J.

J Infect. 2012 Feb;64(2):204-11. doi: 10.1016/j.jinf.2011.10.016. Epub 2011 Nov 25.

PMID:
22138553
20.
21.

Factors associated with liver fibrosis in intravenous drug users coinfected with HIV and HCV.

Cartón JA, Collazos J, de la Fuente B, García-Alcalde ML, Suarez-Zarracina T, Rodríguez-Guardado A, Asensi V.

Antivir Ther. 2011;16(1):27-35. doi: 10.3851/IMP1708.

PMID:
21311106
22.

Immunological status does not influence hepatitis c virus or liver fibrosis in HIV-hepatitis C virus-coinfected patients.

Collazos J, Cartón JA, Asensi V.

AIDS Res Hum Retroviruses. 2011 Apr;27(4):383-9. doi: 10.1089/aid.2010.0168. Epub 2010 Oct 26.

PMID:
20977357
23.

Evaluation of the possible influence of hepatitis C virus and liver fibrosis on HIV type 1 immunological and virological outcomes.

Collazos J, Cartón JA, Asensi V.

HIV Med. 2011 May;12(5):308-15. doi: 10.1111/j.1468-1293.2010.00886.x. Epub 2010 Oct 14.

24.

The MMP1 (-16071G/2G) single nucleotide polymorphism associates with the HAART-related lipodystrophic syndrome.

Montes AH, Valle-Garay E, Suarez-Zarracina T, Melon S, Martinez E, Carton JA, Collazos J, Asensi V.

AIDS. 2010 Oct 23;24(16):2499-506. doi: 10.1097/QAD.0b013e32833e922c.

PMID:
20852404
25.

Effect of simplification from protease inhibitors to boosted atazanavir-based regimens in real-life conditions.

Rubio R, Serrano O, Carmena J, Asensi V, Echevarría S, Flores J, Ribera E, Zarraga M, Ocampo A, de la Fuente B, Sepúlveda MA, Mariño AI, Minguez C, Vicent R, Cartón JA, Moyano B, Esteban H, Mahillo B, Serrano L, González-García J; GESIDA 44/04 SIMPATAZ Study Group.

HIV Med. 2010 Oct 1;11(9):545-53. doi: 10.1111/j.1468-1293.2010.00827.x. Epub 2010 Mar 19.

26.

Meropenem monotherapy is as effective as and safer than imipenem to treat brain abscesses.

Martin-Canal G, Saavedra A, Asensi JM, Suarez-Zarracina T, Rodriguez-Guardado A, Bustillo E, Fierer J, Carton JA, Collazos J, Asensi V.

Int J Antimicrob Agents. 2010 Mar;35(3):301-4. doi: 10.1016/j.ijantimicag.2009.11.012. Epub 2009 Dec 31.

PMID:
20045289
27.

Association of HIV transmission categories with sociodemographic, viroimmunological and clinical parameters of HIV-infected patients.

Collazos J, Asensi V, Carton JA; Grupo Español para el Estudio Multifactorial de la Adherencia (GEEMA).

Epidemiol Infect. 2010 Jul;138(7):1016-24. doi: 10.1017/S0950268809991282. Epub 2009 Nov 27.

PMID:
19941690
28.

Serological screening of Chagas disease in an immigrant population in Asturias, Spain proceeding from Chagas-endemic areas.

Rodríguez-Guardado A, Rodríguez M, Alonso P, Seco C, Flores-Chavez M, Mejuto P, Cartón JA.

Scand J Infect Dis. 2009;41(10):774-6. doi: 10.1080/00365540903161523.

PMID:
19685377
29.

CD4 responses in the setting or suboptimal virological responses to antiretroviral therapy: features, outcomes, and associated factors.

Collazos J, Asensi V, Cartón JA; Grupo Español para el Estudio Multifactorial de la Adherencia (Geema).

AIDS Res Hum Retroviruses. 2009 Jul;25(7):647-55. doi: 10.1089/aid.2008.0098.

PMID:
19621987
30.

[Abdominal and retroperitoneal abscesses in a patient with bladder carcinoma receiving BCG therapy].

Fernández JM, Cartón JA, Rodríguez A, Asensi V.

Enferm Infecc Microbiol Clin. 2009 Oct;27(8):485-6. doi: 10.1016/j.eimc.2008.10.005. Epub 2009 May 5. Spanish. No abstract available.

PMID:
19406520
31.

The influence of the patients' educational levels on socioeconomic, clinical, immunological and virological endpoints.

Collazos J, Asensi V, Carton JA, Ibarra S; Grupo Español para el Estudio Multifactorial de la Adherencia.

AIDS Care. 2009 Apr;21(4):511-9. doi: 10.1080/09540120802270300.

PMID:
19266411
32.

IL-1beta (+3954C/T) polymorphism could protect human immunodeficiency virus (HIV)-infected patients on highly active antiretroviral treatment (HAART) against lipodystrophic syndrome.

Asensi V, Rego C, Montes AH, Collazos J, Carton JA, Castro MG, Alvarez V, Fernández C, Maradona JA, Valle-Garay E.

Genet Med. 2008 Mar;10(3):215-23. doi: 10.1097/GIM.0b013e3181632713.

PMID:
18344712
33.

Multidrug-resistant Acinetobacter meningitis in neurosurgical patients with intraventricular catheters: assessment of different treatments.

Rodríguez Guardado A, Blanco A, Asensi V, Pérez F, Rial JC, Pintado V, Bustillo E, Lantero M, Tenza E, Alvarez M, Maradona JA, Cartón JA.

J Antimicrob Chemother. 2008 Apr;61(4):908-13. doi: 10.1093/jac/dkn018. Epub 2008 Feb 15.

PMID:
18281693
34.

[Efficacy and safety of a reduced-dose of stavudine in HIV-infected patients under immunological and virological stable conditions].

Pedrol E, Martín T, del Pozo MA, Flores J, Sanz J, Cartón JA, Jusdado JJ, Arazo P, Ribera E, Deig E; Grupo de Estudio de Evaluación del uso de Análogos de Nucleósidos.

Med Clin (Barc). 2007 Sep 22;129(10):361-5. Spanish.

PMID:
17915129
35.

Factors associated with poor immunologic responses despite viral suppression in markedly immunosuppressed patients.

Collazos J, Asensi V, Cartón JA; Grupo Español Para El Estudio Multifactorial De La Adherencia (GEEMA).

AIDS Patient Care STDS. 2007 Jun;21(6):378-84.

PMID:
17594246
36.

Bax gene G(-248)A promoter polymorphism is associated with increased lifespan of the neutrophils of patients with osteomyelitis.

Ocaña MG, Valle-Garay E, Montes AH, Meana A, Cartón JA, Fierer J, Celada A, Asensi V.

Genet Med. 2007 Apr;9(4):249-55.

PMID:
17438390
37.
38.

Association between physical and echographic fat thickness assessments and a lipodystrophy grading scale in lipodystrophic HIV patients: practical implications.

Asensi V, Martín-Roces E, Collazos J, Cartón JA, Maradona JA, Alonso A, Medina M, Aburto JM, Fernández C, Martínez E.

AIDS Res Hum Retroviruses. 2006 Sep;22(9):830-6.

PMID:
16989606
39.

The NOS3 (27-bp repeat, intron 4) polymorphism is associated with susceptibility to osteomyelitis.

Asensi V, Montes AH, Valle E, Ocaña MG, Astudillo A, Alvarez V, López-Anglada E, Solís A, Coto E, Meana A, Gonzalez P, Carton JA, Paz J, Fierer J, Celada A.

Nitric Oxide. 2007 Feb;16(1):44-53. Epub 2006 Jun 23.

PMID:
16889995
40.

Post-surgical enterococcal meningitis: clinical and epidemiological study of 20 cases.

Guardado R, Asensi V, Torres JM, Pérez F, Blanco A, Maradona JA, Cartón JA.

Scand J Infect Dis. 2006;38(8):584-8.

PMID:
16857599
41.

Influence of HCV genotype in isolated presence of antibody to hepatitis B core antigen in patients with HIV coinfection.

Rodríguez-Guardado A, Melón S, Rodríguez M, Asensi V, Cartón JA, de Oña M.

J Acquir Immune Defic Syndr. 2006 Aug 15;42(5):647-9. No abstract available.

PMID:
16837869
42.

The Toll-like receptor 4 (Asp299Gly) polymorphism is a risk factor for Gram-negative and haematogenous osteomyelitis.

Montes AH, Asensi V, Alvarez V, Valle E, Ocaña MG, Meana A, Carton JA, Paz J, Fierer J, Celada A.

Clin Exp Immunol. 2006 Mar;143(3):404-13.

43.

Perirenal fat diameter measured by echography could be an early predictor of lipodystrophy in HIV type 1-infected patients receiving highly active antiretroviral therapy.

Asensi V, Martín-Roces E, Carton JA, Collazos J, Maradona JA, Alonso A, Medina M, Aburto JM, Martínez E, Rojo C, Bustillo E, Fernández C, Arribas JM.

Clin Infect Dis. 2004 Jul 15;39(2):240-7. Epub 2004 Jul 1.

PMID:
15307034
44.

Isolated presence of antibody to hepatitis B core antigen in patients coinfected with HIV.

Guardado AR, Pérez MR, Maradona JA, Martínez A, Asensi V, Cartón JA.

J Acquir Immune Defic Syndr. 2004 Aug 1;36(4):988-9. No abstract available.

PMID:
15220708
45.

In vivo interleukin-6 protects neutrophils from apoptosis in osteomyelitis.

Asensi V, Valle E, Meana A, Fierer J, Celada A, Alvarez V, Paz J, Coto E, Carton JA, Maradona JA, Dieguez A, Sarasúa J, Ocaña MG, Arribas JM.

Infect Immun. 2004 Jul;72(7):3823-8.

46.

Factors influencing the development of lipodystrophy in human immunodeficiency virus-infected patients.

Collazos J, Rodriguez-Guardado A, Maradona JA, Mayo J, Asensi V, Ibarra S, Carton JA, Casado L.

Scand J Infect Dis. 2003;35(5):339-40.

PMID:
12875524
47.

IL-1 alpha (-889) promoter polymorphism is a risk factor for osteomyelitis.

Asensi V, Alvarez V, Valle E, Meana A, Fierer J, Coto E, Carton JA, Maradona JA, Paz J, Dieguez MA, de la Fuente B, Moreno A, Rubio S, Tuya MJ, Sarasúa J, Llames S, Arribas JM.

Am J Med Genet A. 2003 Jun 1;119A(2):132-6.

PMID:
12749050
48.

Hepatitis C virus in patients with HIV infection and lipodystrophy.

Rodriguez-Guardado A, Maradona JA, Asensi V, Cartón JA, Casado L.

J Acquir Immune Defic Syndr. 2003 Mar 1;32(3):348-9. No abstract available.

PMID:
12626899
49.

Eikenella corrodens brain abscess after repeated periodontal manipulations cured with imipenem and neurosurgery.

Asensi V, Alvarez M, Carton JA, Lago M, Maradona JA, Asensi JM, Arribas JM.

Infection. 2002 Aug;30(4):240-2.

PMID:
12236570
50.

Triglyceride increase can predict lipodystrophy in HIV patients under highly active antiretroviral therapy.

Rodriguez-Guardado A, Maradona JA, Carton JA, Asensi V.

AIDS. 2002 Jul 5;16(10):1434-6. No abstract available.

PMID:
12131227

Supplemental Content

Loading ...
Support Center